IBANEZ P., BONNET A.M., DEBARGES B., LOHMANN E., TISON F., POLLAK P., AGID Y., DURR A., BRICE
A. and the French Parkinson’s Disease Genetics Study Group.
Causal relation between -synuclein gene duplication and familial Parkinson’s disease.
MALTETE D., NAVARRO S., WELTER M.L., ROCHE S., BONNET A.M., HOUETO J.L., PIDOUX B.,
Subthalamic stimulation in Parkinson’s disease : with or without anesthesia ?
MESNAGE V., HOUETO J.L., BONNET A.M., CLAVIER I., ARNULF I., CATTELIN F., LE FUR G., DAMIER P.,
Neurokinin B, neurotensin and cannabinoid receptor antagonists and Parkinson’s disease.
Clin.Neuropharmacol., 2004, 27(3), 108-110.
PAYOUX P., REMY P., DAMIER P., MILOUDI M., LOUBINOUX I., PIDOUX B., GAURA V., RASCOL O.,
Subthalamic nucleus stimulation reduces abnormal motor cortical overactivity in Parkinson’s disease.
WELTER M.L., HOUETO J.L., BONNET A.M., BEJJANI B.J., MESNAGE V.DORMONT D., NAVARRO S.,
Effects of high-frequency stimulation on subthalamic neuronal activity in Parkinsonian patients.
IBANEZ P., LOHMANN E., POLLAK P., DURIF F., TRANCHANT C., AGID Y., DURR A., BRICE A. for the
French Parkinson’ s Disease Genetics Study Group.
Absence of NR4A2 exon 1 mutations in 108 families with autosomal dominant Parkinson disease. Primary orthostatic tremor and unsteadiness. Centre d'investigation Clinique - Groupe Hospitalier Pitié-Salpêtrière - Batiment Paul Castaigne
47, boulevard de l'Hôpital - 75651 Paris Cedex 13 – France Tél. +33 1 42 16 19 50
POLLAK, P., TISON, F, DESTEE, A., PERE, J.J., SENARD, J.M., DURIF, F., BOURDEIX I., and behalf of the
Clozapine in drug-induced psychosis in Parkinson’s disease : randomized, placebo controlled study with open follow up.
J. Neurol. Neurosurg. Psy., 2004, 75, 689-695.
OLANOW W., AGID Y., MIZUNO Y., ALBANESE A., BONUCELLI U., DAMIER P., DE YEBENES J.,
GERSHANIK O., GUTTMAN M., GRANDAS F., HALLETT M., and al.
Levodopa in the treatment of Parkinson’s disease : Current Controversies.
DORMONT D., RICCIARDI K.G., TANDE D., PARAIN K., MENUEL C., GALANAUD D., NAVARRO S., CORNU
Is the subthalamic nucleus hypointense on T2-Weighted Images ? A correlation study using MR and stereotaxic atlas data.
Am. J. Neuroradiol., 2004, 25, 1516-1523.
CHARFI F., COHEN D., HOUETO J.L., SOUBRIE C., MAZET P.
Tardive dystonia induced by atypical neuroleptics : a case report with Olanzapine. J. of Child and Adolescent
Psychopharmacology, 2004, 14, 1, 151-154.
KREISLER A., STANKOFF B., RIBEIRO M.J., AGID Y., LUBETZKI C., FONTAINE B.
Unexpected aggravation of Parkinson’s disease by a mesencephalic multiple sclerosis lesion.
J. of Neurol., 2004, 215, 12, 1526-1527.
Centre d'investigation Clinique - Groupe Hospitalier Pitié-Salpêtrière - Batiment Paul Castaigne
47, boulevard de l'Hôpital - 75651 Paris Cedex 13 – France Tél. +33 1 42 16 19 50
House of Representatives File No. 159 January Session, 1999 House of Representatives, April 7, 1999 The Committee on Insurance and Real Estate reported throughREP. AMANN of the 118th Dist., Chairperson of theCommittee on the part of the House, that the substitute billought to pass. An Act Requiring Health Insurers to Cover Prescription Birth Control. Be it enacted by the Senate an
TELEMARKETING SKILLS When one of the most important things connecting Presented by Dr. Adalat Khan you and your customer is a telephone line, you have to think fast, know your product/service inside out, and at the same time be courteous and sincere. That's a big job, especially when you want to succeed as a salesperson. It solely depends on what you say, not on what you show or ho
IBANEZ P., BONNET A.M., DEBARGES B., LOHMANN E., TISON F., POLLAK P., AGID Y., DURR A., BRICE
A. and the French Parkinson’s Disease Genetics Study Group.
Causal relation between -synuclein gene duplication and familial Parkinson’s disease. 
POLLAK, P., TISON, F, DESTEE, A., PERE, J.J., SENARD, J.M., DURIF, F., BOURDEIX I., and behalf of the
Clozapine in drug-induced psychosis in Parkinson’s disease : randomized, placebo controlled